SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Mary McLeod Bethune Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMary McLeod Bethune
Date of birth1875-07-10
IdentifiersMRN HR-ML043-SYN-TD; SSN (made up) 000-43-2195
Document date2026-11-01
AuthorViola Harrington-Mbeki, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for four months of wheeze, night cough and breathlessness on exertion in a 72-year-old woman with long-standing asthma that was never confirmed: examination, chest X-ray, ECG, blood tests and BNP, and planning of lung function testing and an echocardiogram. Concerns: Her breathing wakes her at night and stops her climbing stairs, and she has had to travel less; She has been told for years that it is asthma, or her weight, or her heart, and wants to know for certain which it is; She wants to keep going to Washington for the council's meetings. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid)Two puffs every 4 hours as needed; she uses it most daysRespiratory tract route1947-11-03 to 1948-03-23completedS
Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for five days40 mg each morning for five daysOral route1948-06-15 to 1948-06-19completedS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a dayOne inhalation twice daily plus one as neededRespiratory tract route1948-03-23 to 1948-06-15completedS
Budesonide-formoterol 160/4.5 mcg inhaler with a spacer: two inhalations twice daily and one as needed (stepped up during the exacerbation), no more than 12 inhalations a dayTwo inhalations twice daily plus one as neededRespiratory tract route1948-06-15 to 1948-07-27completedS
Budesonide-formoterol 160/4.5 mcg inhaler with a spacer: one inhalation twice daily and one as needed, no more than 12 inhalations a dayOne inhalation twice daily plus one as neededRespiratory tract route1948-07-27activeS
Fluticasone propionate 50 mcg/actuation nasal spray, two sprays in each nostril once daily, aimed away from the septumTwo sprays each nostril dailyNasal route1948-03-23activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril up to four times daily before the steroid sprayTwo sprays each nostril up to four times dailyNasal route1948-03-23activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1948-03-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1948-03-23activeS
Omeprazole 20 mg delayed-release capsule, one capsule daily 30 minutes before breakfast for eight weeksOne capsule daily before breakfastOral route1948-03-23 to 1948-05-18completedS

Procedures

ProcedureDatesStatusEvidence
Chest X-ray, posteroanterior and lateral: mild hyperinflation; heart size normal (cardiothoracic ratio 0.48); no pulmonary edema, effusion, mass or consolidation1948-03-09 to 1948-03-09completedS
Resting 12-lead ECG: sinus rhythm at 80 per minute; left ventricular hypertrophy by voltage criteria; no Q waves, ST changes or arrhythmia1948-03-09 to 1948-03-09completedS
Advance care planning conversation, about 25 minutes, with her consent1948-09-21 to 1948-09-21completedS
Spirometry before and 15 minutes after albuterol 400 mcg, with DLCO and FeNO, interpreted with GLI Global race-neutral equations: FEV1 1.30 L (64 percent predicted) rising to 1.57 L (+270 mL, +21 percent); FEV1/FVC 0.64 before and 0.72 after; DLCO 92 percent predicted; FeNO 46 ppb. Variable airflow obstruction without persistent obstruction: asthma, not COPD1948-03-23 to 1948-03-23completedS
Transthoracic echocardiogram: left ventricular ejection fraction 62 percent; mild concentric left ventricular hypertrophy (septum 1.2 cm); grade 1 diastolic dysfunction; left atrium normal in size; right ventricle normal; estimated pulmonary artery systolic pressure 28 mmHg; no significant valve disease1948-03-23 to 1948-03-23completedS
Written asthma action plan with peak flow zones (green above 270 L/min, yellow 170 to 270, red below 170, based on a provisional best of 340 to be confirmed), given and explained1948-03-23 to 1948-03-23completedS
Nasal endoscopy by the ear, nose and throat specialist: swollen mucosa and mucus in both middle meatuses; no polyps or mass; septum near midline1948-04-20 to 1948-04-20completedS
Inhaler technique assessment with her own inhaler: she did not shake it, breathed in fast and did not hold her breath; retrained with a spacer and checked by teach-back1948-05-04 to 1948-05-04completedS
Spirometry before bronchodilator after stabilization: FEV1 1.72 L (85 percent predicted); FEV1/FVC 0.731948-07-27 to 1948-07-27completedS

Immunizations

DateVaccineStatusEvidence
1946-05-14Recombinant zoster vaccine, dose 2 of 2completedS
1943-02-08Tdap vaccinecompletedS
1948-03-23Pneumococcal conjugate vaccine PCV20completedS
1948-09-21Influenza vaccine, high-dose, this seasoncompletedS
1948-09-21COVID-19 mRNA vaccine, this season's formulacompletedS
1948-09-21Respiratory syncytial virus vaccine, single dosecompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1942Chronic asthma for many years, increasingly limiting her travel; a particularly severe attack in 1942, after which she gave up the presidency of the collegeD (CLM-0005)
1943Repeated asthma attacks recorded in her correspondenceD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Her breathing wakes her at night and stops her climbing stairs, and she has had to travel lessactiveS
She has been told for years that it is asthma, or her weight, or her heart, and wants to know for certain which it isactiveS
She wants to keep going to Washington for the council's meetingsactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 13 on 1948-07-27; Leukocytes [#/volume] in Blood by Automated count 7.1 on 1948-07-27; Eosinophils [#/volume] in Blood by Automated count 0.24 on 1948-07-27; Platelets [#/volume] in Blood by Automated count 255 on 1948-07-27; Sodium [Moles/volume] in Serum or Plasma 140 on 1948-03-09; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1948-07-27; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 1948-07-27; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M 62 on 1948-07-27; Glucose [Mass/volume] in Serum or Plasma 102 on 1948-03-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.9 on 1948-03-09; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 1948-03-09; Natriuretic peptide B [Mass/volume] in Serum or Plasma 48 on 1948-03-09; Cholesterol [Mass/volume] in Serum or Plasma 170 on 1948-05-04; Cholesterol in HDL [Mass/volume] in Serum or Plasma 57 on 1948-05-04; Triglyceride [Mass/volume] in Serum or Plasma 126 on 1948-05-04; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 88 on 1948-05-04; Albumin/Creatinine [Mass Ratio] in Urine 18 on 1948-03-09; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1948-07-27; Total score [ACT] 22 on 1948-07-27; Maximum expiratory gas flow Respiratory system airway by Peak flow meter 330 on 1948-07-27; Total score [Mini-Cog] 5 on 1948-09-21; Total score [AUDIT-C] 0 on 1948-09-21; FEV1 --pre bronchodilation 1.72 on 1948-07-27; FEV1 --post bronchodilation 1.57 on 1948-03-23; FEV1 measured/predicted 85 on 1948-07-27; FEV1/FVC 0.73 on 1948-07-27; FEV1/FVC --post bronchodilation 0.72 on 1948-03-23; Diffusion capacity.carbon monoxide 17.2 on 1948-03-23; Fractional concentration of exhaled nitric oxide 21 on 1948-07-27; Left ventricular Ejection fraction 62 on 1948-03-23; IgE [Units/volume] in Serum or Plasma 210 on 1948-03-23 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram bookedresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented chronic asthma. Superseded by the diagnosis at the second visit.
Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialistresolvedconfirmed R09.81S — Synthetic upper-airway symptoms; superseded by the diagnosis of chronic rhinosinusitis after nasal endoscopy.
Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight lossactiveconfirmed K21.9S — Synthetic comorbidity of asthma; not a claim about her real health.
Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about itactiveconfirmed E66.811S — Synthetic comorbidity recorded in her words and with her agreement; not a claim about her real weight.
Moderate asthma exacerbation triggered by a cold: two days of worsening wheeze and night waking despite eight reliever inhalations a day, peak flow 205 L/min (60 percent of her best), oxygen saturation 94 percent; improved to 275 L/min in clinic; treated without admission; resolvedresolvedconfirmed J45.41S — Synthetic exacerbation; not a claim about a real attack.
Asthma, confirmed: variable airflow obstruction (FEV1 64 percent predicted, rising 270 mL or 21 percent after bronchodilator, with a normal post-bronchodilator FEV1/FVC of 0.72 and normal DLCO); type 2 inflammation (FeNO 46 ppb, blood eosinophils 0.42 x10^3/uL, total IgE 210, house dust mite sensitization); not COPD and not heart failure. Uncontrolled at diagnosis on albuterol aloneactiveconfirmed J45.40S — Synthetic modern confirmation linked to her documented chronic asthma.
Hypertensive heart disease without heart failure: clinic blood pressure 152/88 and 146/86, home average 144/84; mild concentric left ventricular hypertrophy with grade 1 diastolic dysfunction and a normal ejection fraction (62 percent); BNP 48 pg/mLactiveconfirmed I11.9S — Synthetic finding of the modern work-up; not a claim about her real heart.
Hyperlipidemia: LDL cholesterol 144 mg/dL; 10-year ASCVD risk above 20 percent with hypertensionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor.
Chronic rhinosinusitis without nasal polyps: years of congestion, postnasal drip and reduced smell, with mucosal swelling and mucus in both middle meatuses and no polyps on nasal endoscopyactiveconfirmed J32.9S — Synthetic upper-airway comorbidity of asthma; not a claim about her real health.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1948-03-09Hemoglobin [Mass/volume] in Blood12.9g/dL12-15.5 g/dLNormalS
1948-03-09Leukocytes [#/volume] in Blood by Automated count7.610*3/uL4-11 10*3/uLNormalS
1948-03-09Eosinophils [#/volume] in Blood by Automated count0.4210*3/uL0-0.5 10*3/uLNormalS
1948-03-09Platelets [#/volume] in Blood by Automated count26810*3/uL150-400 10*3/uLNormalS
1948-03-09Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1948-03-09Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1948-03-09Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1948-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M66mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1948-03-09Glucose [Mass/volume] in Serum or Plasma102mg/dL70-99 mg/dLHighS
1948-03-09Hemoglobin A1c/Hemoglobin.total in Blood5.9%Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetesHighS
1948-03-09Thyrotropin [Units/volume] in Serum or Plasma2.2m[IU]/L0.4-4 mIU/LNormalS
1948-03-09Natriuretic peptide B [Mass/volume] in Serum or Plasma48pg/mLBelow 100 pg/mL makes heart failure unlikelyNormalS
1948-03-09Cholesterol [Mass/volume] in Serum or Plasma228mg/dL<=199 mg/dLHighS
1948-03-09Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL50 mg/dL or more for womenNormalS
1948-03-09Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
1948-03-09Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation144mg/dL<=99 mg/dLHighS
1948-03-09Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=30 mg/gNormalS
1948-03-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1948-03-09Total score [ACT]13{score}S
1948-06-15Maximum expiratory gas flow Respiratory system airway by Peak flow meter205L/min80 percent of her personal best of 340 L/minLowS
1948-09-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1948-09-21Total score [Mini-Cog]5{score}S
1948-09-21Total score [AUDIT-C]0{score}S
1948-03-23FEV1 --pre bronchodilation1.3LLower limit of normal, GLI Global race-neutral equations; predicted 2.03 LLowS
1948-03-23FEV1 --post bronchodilation1.57LLower limit of normal, GLI Global race-neutral equations; predicted 2.03 LNormalS
1948-03-23FEV1 measured/predicted64%GLI Global race-neutral equationsLowS
1948-03-23FEV1/FVC0.64{ratio}>=0.7LowS
1948-03-23FEV1/FVC --post bronchodilation0.72{ratio}0.70 or more after bronchodilator: no persistent airflow obstructionNormalS
1948-03-23Diffusion capacity.carbon monoxide17.2mL/min/mm[Hg]Lower limit of normal, GLI race-neutral; predicted 18.6NormalS
1948-03-23Fractional concentration of exhaled nitric oxide46[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)HighS
1948-03-23Left ventricular Ejection fraction62%53-73%NormalS
1948-03-23IgE [Units/volume] in Serum or Plasma210[IU]/mL<=100 [IU]/mLHighS
1948-03-23Total score [ACT]14{score}S
1948-05-04Total score [ACT]18{score}S
1948-05-04Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1948-05-04Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.59-1.04 mg/dLNormalS
1948-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M64mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1948-05-04Cholesterol [Mass/volume] in Serum or Plasma170mg/dL<=199 mg/dLNormalS
1948-05-04Cholesterol in HDL [Mass/volume] in Serum or Plasma57mg/dL50 mg/dL or more for womenNormalS
1948-05-04Triglyceride [Mass/volume] in Serum or Plasma126mg/dL<=149 mg/dLNormalS
1948-05-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation88mg/dL<=99 mg/dLNormalS
1948-07-27Total score [ACT]22{score}S
1948-07-27FEV1 --pre bronchodilation1.72LLower limit of normal, GLI Global race-neutral equations; predicted 2.03 LNormalS
1948-07-27FEV1 measured/predicted85%GLI Global race-neutral equationsNormalS
1948-07-27FEV1/FVC0.73{ratio}>=0.7NormalS
1948-07-27Fractional concentration of exhaled nitric oxide21[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)NormalS
1948-07-27Maximum expiratory gas flow Respiratory system airway by Peak flow meter330L/min80 percent of her personal best of 340 L/minNormalS
1948-07-27Hemoglobin [Mass/volume] in Blood13g/dL12-15.5 g/dLNormalS
1948-07-27Leukocytes [#/volume] in Blood by Automated count7.110*3/uL4-11 10*3/uLNormalS
1948-07-27Eosinophils [#/volume] in Blood by Automated count0.2410*3/uL0-0.5 10*3/uLNormalS
1948-07-27Platelets [#/volume] in Blood by Automated count25510*3/uL150-400 10*3/uLNormalS
1948-07-27Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1948-07-27Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.59-1.04 mg/dLNormalS
1948-07-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M62mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1948-07-27Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1948-03-09Body height163cmS
1948-03-09Body weight88kgS
1948-03-09Body mass index (BMI) [Ratio]33.1kg/m2S
1948-03-09Systolic blood pressure152mm[Hg]S
1948-03-09Diastolic blood pressure88mm[Hg]S
1948-03-09Heart rate82/minS
1948-03-09Respiratory rate20/minS
1948-03-09Body temperature36.7CelS
1948-03-09Oxygen saturation in Arterial blood by Pulse oximetry95%S
1948-06-15Body height163cmS
1948-06-15Body weight87.2kgS
1948-06-15Body mass index (BMI) [Ratio]32.8kg/m2S
1948-06-15Systolic blood pressure138mm[Hg]S
1948-06-15Diastolic blood pressure82mm[Hg]S
1948-06-15Heart rate98/minS
1948-06-15Respiratory rate22/minS
1948-06-15Body temperature37.4CelS
1948-06-15Oxygen saturation in Arterial blood by Pulse oximetry94%S
1948-09-21Body height163cmS
1948-09-21Body weight86kgS
1948-09-21Body mass index (BMI) [Ratio]32.4kg/m2S
1948-09-21Systolic blood pressure126mm[Hg]S
1948-09-21Diastolic blood pressure76mm[Hg]S
1948-09-21Heart rate70/minS
1948-09-21Respiratory rate16/minS
1948-09-21Body temperature36.6CelS
1948-09-21Oxygen saturation in Arterial blood by Pulse oximetry97%S
1948-03-23Body height163cmS
1948-03-23Body weight87.6kgS
1948-03-23Body mass index (BMI) [Ratio]33kg/m2S
1948-03-23Systolic blood pressure146mm[Hg]S
1948-03-23Diastolic blood pressure86mm[Hg]S
1948-03-23Heart rate78/minS
1948-03-23Respiratory rate18/minS
1948-03-23Body temperature36.6CelS
1948-03-23Oxygen saturation in Arterial blood by Pulse oximetry96%S
1948-05-04Body height163cmS
1948-05-04Body weight87kgS
1948-05-04Body mass index (BMI) [Ratio]32.7kg/m2S
1948-05-04Systolic blood pressure134mm[Hg]S
1948-05-04Diastolic blood pressure80mm[Hg]S
1948-05-04Heart rate76/minS
1948-05-04Respiratory rate16/minS
1948-05-04Body temperature36.6CelS
1948-05-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
1948-07-27Body height163cmS
1948-07-27Body weight86.4kgS
1948-07-27Body mass index (BMI) [Ratio]32.5kg/m2S
1948-07-27Systolic blood pressure128mm[Hg]S
1948-07-27Diastolic blood pressure78mm[Hg]S
1948-07-27Heart rate72/minS
1948-07-27Respiratory rate16/minS
1948-07-27Body temperature36.5CelS
1948-07-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
1948-03-09New patient visit for four months of wheeze, night cough and breathlessness on exertion in a 72-year-old woman with long-standing asthma that was never confirmed: examination, chest X-ray, ECG, blood tests and BNP, and planning of lung function testing and an echocardiogramfinishedS
1948-03-23Diagnosis visit: spirometry, FeNO and echocardiogram results with the pulmonology consultation; asthma confirmed, heart failure excluded, hypertensive heart disease found; start of budesonide-formoterol as maintenance and relieverfinishedS
1948-05-04Six-week asthma review: control, inhaler technique and adherence, the ear, nose and throat result, blood pressure and refluxfinishedS
1948-07-27Review six weeks after an exacerbation: control, repeat spirometry and FeNO, biologic assessment, blood pressure and the post-exacerbation planfinishedS
1948-06-15Same-day sick visit for an asthma exacerbation with a coldfinishedS
1948-09-21Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Pulmonology consultation in two weeks with spirometry before and after bronchodilator, DLCO and FeNO, to confirm or refute asthma, separate it from COPD and heart disease, and plan treatmentcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026S
Work-up of wheeze and breathlessness: chest X-ray, ECG, blood count with eosinophils, BNP, TSH and kidney function today; transthoracic echocardiogram before the consultation; albuterol continued as needed until testing, holding it for six hours before spirometrycompletedGL-GINA-2025, GL-NAEPP-2020, GL-AHA-HF-2022S
Home blood pressure readings twice daily for a week, with a validated upper-arm cuff, because clinic readings are raisedcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Equity safeguards: spirometry read with race-neutral GLI Global equations, plain explanation of every result, and a check at each visit that her symptoms are not put down to her weight or agecompletedGL-ATS-RACE-2023, GL-MMWR-ASTHMA-2021S
GINA track 1: budesonide-formoterol 160/4.5 mcg as maintenance and reliever (one inhalation twice daily and one as needed, no more than 12 a day), albuterol stopped; inhaler technique, adherence and Asthma Control Test at every visit; a written asthma action plan with peak flow zones; review six weeks after any change and within a week of any exacerbationcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026S
Hypertensive heart disease without heart failure: amlodipine 5 mg daily (a beta-blocker avoided because of asthma), a lower-salt diet, home readings, and kidney function and potassium at follow-upcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Cardiovascular prevention: atorvastatin 20 mg daily for a 10-year ASCVD risk above 20 percentcompletedGL-AHA-HTN-2025S
Upper airway and reflux: fluticasone nasal spray and saline rinses, ear, nose and throat review with nasal endoscopy; omeprazole for eight weeks for heartburn with meal timing and head-of-bed elevation, then stop if settledcompletedGL-GINA-2025, GL-CMID-2026S
Weight and fitness, as she chooses: a dietitian visit, a walking plan she can follow on campus and in Washington, and a later discussion of medicines for weight if she wants onecompletedGL-GINA-2025, GL-CMID-2026S
Biologic assessment: not indicated while asthma is controlled on low-to-medium dose ICS-formoterol with good technique; repeat blood eosinophils and refer for biologic therapy if asthma becomes uncontrolled on step 4 to 5 treatment or there are two or more exacerbations needing oral corticosteroids in a yearcompletedGL-GINA-2025, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
A confirmed diagnosis within three weeks: spirometry with bronchodilator response, FeNO and an echocardiogram, with the pulmonology consultation1948-03-23completedAsthma confirmed by a 21 percent, 270 mL bronchodilator response and FeNO 46 ppb; heart failure excluded; hypertensive heart disease found, two weeks after the first visitS
Asthma Control Test 20 or more, no night waking, and travel to Washington without breathlessness1948-07-27completedAsthma Control Test 22; no night waking; travelled to two board meetingsS
Correct inhaler technique with her own inhaler at every visit, and a written asthma action plan she can use1948-05-04completedTechnique corrected with a spacer at six weeks; action plan written at diagnosis and used during the exacerbationS
Blood pressure below 130/80 at home and in clinic1948-07-27completedClinic 128/78; home average 126/76 on amlodipineS
No exacerbation needing oral corticosteroids1948-07-27completedNot achieved: one moderate exacerbation with a cold, treated with five days of prednisone without admissionS

Functional Status

Mental Status